BMO Capital resumed coverage of Affirm (AFRM) with an Outperform rating and $69 price target The shares are down over 40% from recent highs as ...

BMO Capital Markets’ price target points to a potential upside of 21.99% from the company’s current price. A number of other research firms have also issued reports on DT.

Shares of Algoma Central stock opened at C$14.98 on Monday. Algoma Central has a one year low of C$14.03 and a one year high of C$15.60. The firm has a market capitalization of C$613.30 million, a ...

BMO Capital keeps an Outperform rating and $495 price target on Adobe (ADBE) after the company’s analyst event presentation that was focused on ...

Taylor Swift wrapped up her monumental Eras Tour last year, but Nvidia is on one of its own, according to BMO Capital Markets analyst Brian Pitz. "We are entering the era of general physical AI," he ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...

BMO raised $618m on Tuesday in its first CMBS conduit deal to be backed by five-year loans this year, but was forced to widen ...

Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...